RSS-Feed abonnieren
DOI: 10.1055/s-2006-947365
An Efficient Catalyst System for Palladium-Catalyzed Borylation of Aryl Halides with Pinacolborane
Publikationsverlauf
Publikationsdatum:
24. Juli 2006 (online)
Abstract
The combination of Pd(dba)2 and bis(2-di-tert-butylphosphinophenyl)ether has proven to be efficient for the cross-coupling of pinacolborane with aryl bromides and chlorides. The substrate scope is broad and the present system enables the synthesis of ortho-, meta-, and para-substituted electron-rich and -deficient arylboronates.
Key words
boron - palladium - catalysis - cross-coupling - ligands
- For reviews of the Suzuki coupling, see:
-
1a
Miyaura N.Suzuki A. Chem. Rev. 1995, 95: 2457 -
1b
Miyaura N. Adv. Organomet. Chem. 1998, 6: 187 -
1c
Miyaura N. Top. Curr. Chem. 2002, 219: 11 - For reviews of the Miyaura borylation, see:
-
2a
Ishiyama T.Miyaura N. J. Organomet. Chem. 2000, 611: 392 -
2b
Ishiyama T.Miyaura N. Chem. Rec. 2004, 3: 271 -
3a
Murata M.Watanabe S.Masuda Y. J. Org. Chem. 1997, 62: 6458 -
3b
Murata M.Oyama T.Watanabe S.Masuda Y. J. Org. Chem. 2000, 65: 164 -
4a
Murata M.Watanabe S.Masuda Y. Tetrahedron Lett. 2000, 41: 5877 -
4b
Murata M.Oyama T.Watanabe S.Masuda Y. Synthesis 2000, 778 -
4c
Murata M.Oyama T.Watanabe S.Masuda Y. Synth. Commun. 2002, 32: 2513 - 5
Baudoin O.Guénard D.Guéritte F. J. Org. Chem. 2000, 65: 9268 - 6
Doux M.Mézailles N.Melaimi M.Ricard L.LeFloch P. Chem. Commun. 2002, 1566 - 7
Wolan A.Zaidlewicz M. Org. Biomol. Chem. 2003, 1: 3274 - 8
Broutin P.-E.Čerña I.Campaniello M.Leroux F.Colobert F. Org. Lett. 2004, 6: 4419 - 9
Murata M.Buchwald SL. Tetrahedron 2004, 60: 7397 - 10
Hamann BC.Hartwig JF. J. Am. Chem. Soc. 1998, 120: 7369 - 11
t-Bu-DPEphos (L8) was prepared from diphenylether and (t-Bu)2PCl by a similar procedure for the preparation of DPEphos. See:
Kranenburg M.Vanderburgt YEM.Kamer PCJ.van Leeuwen PWNM.Goubitz K.Fraanje J. Organometallics 1995, 14: 3081 - 12 For a review of the palladium-catalyzed couplings of aryl chlorides, see:
Littke AF.Fu GC. Angew. Chem. Int. Ed. 2002, 41: 4176
References and Notes
Compound 3d: 1H NMR (CDCl3): δ = 1.35 (s, 12 H), 7.47 (t, J = 7.9 Hz, 1 H), 7.73 (d, J = 7.9 Hz, 1 H), 8.01 (d, J = 7.9 Hz, 1 H), 8.09 (s, 1 H). 13C NMR (CDCl3): δ = 24.81, 84.46, 111.95, 118.79, 128.36, 134.37, 138.37, 138.73. HRMS (EI): m/z calcd for C13H16BNO2 [M+]: 229.1274; found: 229.1312. IR (KBr): 2228 cm-1.
Compound 3f: 1H NMR (CDCl3): δ = 1.36 (s, 12 H), 7.61 (d, J = 7.9 Hz, 2 H), 7.92 (d, J = 7.9 Hz, 2 H). 13C NMR (CDCl3): δ = 24.98, 84.25, 124.29 (q, J = 4 Hz), 124.13 (q, J = 272 Hz), 132.80 (q, J = 32 Hz), 135.21. HRMS (EI): m/z calcd for C13H16BF3O2 [M+]: 272.1196; found: 272.1229.
Compound 3g: 1H NMR (CDCl3): δ = 1.21 (s, 12 H), 7.30-7.50 (m, 8 H), 7.71 (d, J = 7.8 Hz, 1 H). 13C NMR (CDCl3): δ = 24.55, 83.69, 126.23, 126.79, 127.74, 128.92, 129.08, 130.03, 134.40, 143.19, 147.46. HRMS (EI): m/z calcd for C18H21BO2 [M+]: 280.1635; found: 280.1629.
Compound 3i: 1H NMR (CDCl3): δ = 1.21 (d, J = 6.7 Hz, 6 H), 1.25 (d, J = 6.7 Hz, 12 H), 1.37 (s, 12 H), 2.84 (sept, J = 6.7 Hz, 1 H), 2.98 (sept, J = 6.7 Hz, 2 H), 6.93 (s, 2 H). 13C NMR (CDCl3): δ = 24.01, 24.55, 24.98, 34.00, 34.49, 83.61, 119.63, 149.72, 151.86. HRMS (EI): m/z calcd for C21H35BO2 [M+]: 330.2730; found: 330.2773.
Compound 3j: 1H NMR (CDCl3): δ = 1.32 (s, 12 H), 2.86 (d, J = 5.5 Hz, 3 H), 3.92 (br s, 1 H), 6.58 (d, J = 8.5 Hz, 2 H), 7.65 (d, J = 8.5 Hz, 2 H). 13C NMR (CDCl3): δ = 24.79, 30.22, 83.13, 111.38, 136.26, 151.74. HRMS (EI): m/z calcd for C13H20BNO2 [M+]: 233.1587; found: 233.1611.
IR (KBr): 3425, 3401, 3375 cm-1.